Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind adjuvant justification study of RTS,S/AS01B vs RTS,S/AS02A in malaria-naive adults
2006-002095-18Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RTS,S in malaria and Falciparum malaria (PF) (2 arms), sponsored by GSK. Primary endpoints: Immunogenicity and Safety. Started Feb 2007; status: completed.
02
Drugs
RTS,S
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on 2006-002095-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002095-18.